Ledger.Open graph →
SEC Form D · filed March 4, 2016

Pharma Analytics Corp

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
ATLANTA, GA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Kevin Leininger · Philadelphia, PAExec · DirectorAdi Filipovic · Atlanta, GAExec · DirectorDarren Weiss · Philadelphia, PAExecFred Sturgis · Atlanta, GAExec · DirectorAndris K. Berzins · Tallinn, 1HExec · DirectorHarry Huge · Charleston, SCExec · DirectorYrjo K. Ojasaar · Tallinn, 1HExec · DirectorVentures OU Change · Tallinn, 1HExecDavid Blue · Idaho Falls, IDExec · DirectorRod R. Jensen · Afton, WYExec · DirectorLynn E. Fedor · Peachtree City, GAExecCharles A. Kiene · Savannah, GAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗